InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $136.390 0.85 (0.62%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8,920 COH - F10 Preliminary Final Report - Appendix 4E 10 Aug 2010 9:05AM $69.860 $136.390 risen by 95.23%
$8,920 Settlement Agreement with the DOJ and OIG 4 Jun 2010 9:46AM $74.820 $136.390 risen by 82.29%
$8,920 Response to ASX Price Query 26 Mar 2010 2:06PM $72.480 $136.390 risen by 88.18%
$8,920 COH Half Year Report as at 31 December 2009 09.02.10 9 Feb 2010 9:25AM $63.550 $136.390 risen by 114.62%
$8,920 Technnology Purchase Towards a Totally Implantable Cochlear 9 Sep 2009 8:44AM $60.400 $136.390 risen by 125.81%
$8,920 FDA Approval for Nucleus 5 System 4 Sep 2009 1:49PM $61.170 $136.390 risen by 122.97%
$8,920 Full Year Statutory Accounts 11 Aug 2009 9:00AM $58.660 $136.390 risen by 132.51%
$8,920 COH Market Update 14th July 2009 14 Jul 2009 9:22AM $51.970 $136.390 risen by 162.44%
$8,920 COH Media Release Half Year Accounts 10.02.09 10 Feb 2009 9:59AM $55.000 $136.390 risen by 147.98%
$8,920 COH Half Year Accounts Appendix 4D 10.02.09 10 Feb 2009 9:58AM $55.000 $136.390 risen by 147.98%
$8,920 Full Yearly Report as at 30 June 2008 12 Aug 2008 9:45AM $49.770 $136.390 risen by 174.04%
$8,920 Half Yearly Report and Accounts Appendix 4D 12 Feb 2008 9:30AM $53.840 $136.390 risen by 153.32%
$8,920 Cochlear to Vigorously Defend Patent Infringement Complaint 21 Dec 2007 12:49PM $72.580 $136.390 risen by 87.92%
$8,920 23/10/07 Cochlears Plans for New Sydney Global Headquarters 23 Oct 2007 2:01PM $70.320 $136.390 risen by 93.96%
$8,920 COH Preliminary Final Report Full Year Accounts 14-08-07 14 Aug 2007 9:59AM $63.250 $136.390 risen by 115.64%
$8,920 Half Yearly Report & Half Year Accounts 13 Feb 2007 9:42AM $57.850 $136.390 risen by 135.76%
$8,920 Expands Manufacturing Capability 19 Dec 2006 8:57AM $56.070 $136.390 risen by 143.25%
$8,920 Preliminary Final Report/Full Year Accounts 15 Aug 2006 10:01AM $48.500 $136.390 risen by 181.22%
$8,920 Approx. $270m China Order 5 May 2006 12:28PM $54.000 $136.390 risen by 152.57%
$8,920 Half Yearly Report & Half Year Accounts 14 Feb 2006 10:21AM $50.900 $136.390 risen by 167.96%
$8,920 F06 Full Year Earnings Upgrade 14 Dec 2005 10:07AM $43.440 $136.390 risen by 213.97%
$8,920 Preliminary Final Report 16 Aug 2005 10:08AM $39.510 $136.390 risen by 245.20%
$8,920 Response to ASX Query - Share Price 27 Sep 2004 4:29PM $24.350 $136.390 risen by 460.12%
$8,920 CEO Update 27 Apr 2004 10:18AM $18.900 $136.390 risen by 621.64%
$8,920 CEO Update 27 Apr 2004 10:18AM $18.900 $136.390 risen by 621.64%

901 - 925 of 933 results

Page 37 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.